Black Diamond Therapeutics (BDTX)
(Delayed Data from NSDQ)
$7.20 USD
-0.19 (-2.57%)
Updated May 7, 2024 04:00 PM ET
After-Market: $7.19 -0.01 (-0.14%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.44 |
EPS Last Quarter | -0.34 |
Last EPS Surprise | 27.66% |
ABR | 1.00 |
Earnings ESP
|
5.75% |
---|---|
Current Year | -1.71 |
Next Year | -1.79 |
EPS (TTM) | -1.88 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.44 | -0.43 | -1.71 | -1.79 |
# of Estimates | 6 | 5 | 6 | 5 |
Most Recent Consensus | -0.41 | -0.35 | -1.49 | -1.58 |
High Estimate | -0.40 | -0.35 | -1.49 | -1.58 |
Low Estimate | -0.52 | -0.52 | -1.87 | -2.01 |
Year ago EPS | -0.57 | -0.52 | -1.88 | -1.71 |
Year over Year Growth Est. | 22.81% | 17.31% | 9.04% | -4.46% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 3 | 3 | 6 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.44 | -0.43 | -1.71 | -1.79 |
7 Days Ago | -0.44 | -0.43 | -1.71 | -1.79 |
30 Days Ago | -0.45 | -0.47 | -1.76 | -1.86 |
60 Days Ago | -0.52 | -0.53 | -2.05 | -2.15 |
90 Days Ago | -0.52 | -0.53 | -2.05 | -2.15 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.41 | -0.35 | -1.49 | -1.58 |
Zacks Consensus Estimate | -0.44 | -0.43 | -1.71 | -1.79 |
Earnings ESP | 5.75% | 18.61% | 12.95% | 11.63% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.34 | -0.45 | -0.52 | -0.57 | NA |
Estimate | -0.47 | -0.49 | -0.54 | -0.61 | NA |
Difference | 0.13 | 0.04 | 0.02 | 0.04 | 0.06 |
Surprise | 27.66% | 8.16% | 3.70% | 6.56% | 11.52% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more